PETER SEILER: Open Payments
NPI 1881072254 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 48 payments from 12 companies in 2025. Trend: 2023 $900 · 2024 $1,536 · 2025 $944
Food & beverage: $832Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $227 |
| Corium, LLC | 12 | $149 |
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| Neurocrine BioSciences, Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 2 | $76 |
| Lundbeck LLC | 3 | $57 |
| Almatica Pharma LLC | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: Azstarys, COBENFY, INGREZZA, Auvelity, AUSTEDO XR, REXULTI, LOREEV XR, UZEDY.
Industry payments across KS — which companies pay providers there.
